MADALYN WHITE: Open Payments
NPI 1134764798 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 58 payments from 10 companies in 2025. Trend: 2023 $526 · 2024 $311 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 46 | $470 |
| Organon LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| MILLICENT US INC | 2 | $36 |
| Becton, Dickinson and Company | 1 | $25 |
| Biogen, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: NEXPLANON, Wegovy, FEMLYV, ARISTA, ZURZUVAE, ZEPBOUND, Veozah, The Cologuard Plus Collection Kit.
Industry payments across VA — which companies pay providers there.
